摘要
目的:比较微创23G与传统20G玻璃体切除术治疗玻璃体视网膜疾病患者的效果。方法:选取2018年9月至2021年10月河南科技大学第一附属医院收治的80例玻璃体视网膜疾病患者进行前瞻性研究,按照随机数字表法分为对照组和观察组各40例。对照组采用传统20G传统玻璃体切除术治疗,观察组采用微创23G玻璃体切除术治疗,比较两组临床疗效、治疗前后眼压水平及并发症发生率。结果:观察组治疗总有效率为97.50%,高于对照组的85.00%,差异有统计学意义(P<0.05);治疗后1、3、7 d,观察组眼压水平均低于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为5.00%,低于对照组的25.00%,差异有统计学意义(P<0.05)。结论:微创23G玻璃体切除术治疗玻璃体视网膜疾病患者,可提高临床疗效,稳定患者眼压,降低并发症发生率,其效果优于传统20G玻璃体切除术治疗。
Objective:To compare effects of traditional 20G and minimally invasive 23G vitrectomy in treatment of patients with vitreoretinal diseases.Methods:A prospective study was performed on 80 patients with vitreoretinal diseases admitted to the first affiliated hospital of Henan university of science and technology from September 2018 to October 2021,and they were divided into control group and observation group according to the random number table method,40 cases in each group.The control group was treated with traditional 20G traditional vitrectomy,while the observation group was treated with minimally invasive 23G vitrectomy.The clinical efficacy,the intraocular pressure levels before and after the treatment and the incidence of complications were compared between the two groups.Results:The total effective rate of the observation group was 97.50%,which was higher than 85.00%of the control group,and the difference was statistically significant(P<0.05).1,3,and 7 days after the treatment,the intraocular pressure levels of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).Further,the incidence of complications in the observation group was 5.00%,which was lower than 25.00%in the control group,and the difference was statistically significant(P<0.05).Conclusions:Minimally invasive 23G vitrectomy in the treatment of the patients with vitreoretinal diseases can improve clinical efficacy,stabilize the intraocular pressure,and reduce the incidence of complications.Moreover,it is superior to traditional 20G vitrectomy.
作者
张明华
闫俊茹
ZHANG Minghua;YAN Junru(Department of Ophthalmology of the First Affiliated Hospital of Henan University of Science and Technology,Clinical Medical College of Henan University of Science and Technology,Luoyang 471000 Henan,China;Department of Ophthalmology of Zhumadian Eye Hospital,Zhumadian 463000 Henan,China)
出处
《中国民康医学》
2022年第18期142-144,共3页
Medical Journal of Chinese People’s Health
关键词
玻璃体视网膜疾病
微创
玻璃体切除术
眼压
并发症
Vitreoretinal disease
Minimally invasive
Vitrectomy
Intraocular pressure
Complication
